We evaluated patients with CNV secondary to multifocal choroiditis (MFC) with FA and OCT, and characterised the nature of the CNV and the concordance between these two diagnostic modalities in detecting it.
METHODS
We conducted a retrospective analysis of consecutive, symptomatic patients with MFC in a referral practice. The objective of the study was to evaluate the clinical characteristics and nature of CNV in this Only patients with a diagnosis of MFC who exhibited acute visual deficits and clinical manifestations of active CNV were included in the study. The active CNV was diagnosed by biomicroscopy and the typical findings seen on FA such as early hyperfluorescence with late dye leakage. Disciform scars at separate sites than the active CNV, in the same or fellow eye, were not included. Other exclusion criteria were: features of other neovascular maculopathies such as age-related macular degeneration; hereditary retinal disorders or idiopathic CNV; previous therapeutic interventions such as submacular surgery, laser photocoaguation, photodynamic therapy (PDT) or anti-vascular endothelial growth factor (anti-VEGF) pharmacotherapy; and underlying ocular or systemic inflammatory or infectious diseases such as presumed ocular histoplasmosis (POHS,) tuberculosis and sarcoidosis.
Each patient received a comprehensive ophthalmic examination which included Snellen distant visual acuity measurement to determine best-corrected visual acuity (BCVA), intraocular pressure, slit-lamp biomicroscopy, indirect ophthalmoscopy and FA and OCT findings. OCT imaging was carried out using a Stratus OCT camera (Carl Zeiss Meditec, Dublin, California, USA) or a Spectralis HRA+OCT (Heidelberg Engineering, Heidelberg, Germany). Primary outcome measures included CNV classification (type 1 or occult and type 2 or classic), location and the associated FA and OCT findings, specifically alterations of the retinal architecture and existence of subretinal fluid (SRF) or intraretinal cysts.
RESULTS
Twenty eyes from 17 patients were included in the study. There were 14 women and three men ranging in age from 29 to 78 years with a mean age of 42.7 years. The BCVA ranged from 20/25 to 10/400 with a mean of 20/100 and the mean spherical equivalent ranged from À1.50 to À16.00 with a mean of À7.3 dioptres (for five eyes the spherical equivalent data was not available). Eleven cases revealed a history of corticosteroid therapy: oral medication (nine), subtenon's injection (one) and intravenous medication (one). Additionally, seven eyes showed old CNV scars in the same or fellow eye without evidence of active leakage with FA and these lesions were excluded from analysis.
In five eyes (25%) the active choroidal neovascularisation was subfoveal, in 11 (55%) juxtafoveal and in four (20%) extrafoveal (table 1) .
In 19 eyes (95%) the early phase of FA revealed a welldemarcated area of hyperfluorescence indicative of type 2 or classic CNV followed by late dye leakage (figure 1). In one eye (5%) the type of CNV was indeterminate due to a subretinal haemorrhage which obscured most of the lesion.
OCT data was available for 13 eyes (12 patients). In all eyes, the OCT imaging of the active CNV lesions revealed an area of hyper-reflectivity beneath the neurosensory retina ( figure 2) . Only 53.8% of these eyes revealed subretinal fluid (SRF) or intraretinal cystic changes. Three eyes (23%) developed intraretinal cysts without SRF, four eyes (31%) developed SRF without intraretinal cysts and one eye (7.7%) developed SRF and intraretinal cysts. In six eyes (46%) no evidence of fluid accumulation was observed (figure 3).
DISCUSSION
In virtually all of our acute MFC cases (19 of 20), the clinical and angiographic findings demonstrated type 2 neovascularisation or so-called classic CNV. The one exception was indeterminate because of a subretinal haemorrhage which obscured the lesion. Our findings are in accordance with other studies involving CNV in MFC. 3 4 In type 2 CNV, as introduced by Gass, the neovascular membrane proliferates beneath the neurosensory retina rather than beneath the retinal pigment epithelium (RPE). 5 An explanation for the development of this type of CNV in MFC is inherent in the inflammatory nature of the abnormality. The lesions in MFC are located at the level of the RPE and inner choroid leading to disruptions of the choriocapillariseBruch's membraneeRPE complex; in some cases there is infiltration of the retina, essentially a chorioretinal inflammatory spot. These lesions are focal or multifocal but not diffuse as in ARMD. Bruch's membrane remains attached to the pigment epithelium and prevents the choroidal vessels from proliferating beneath the RPE. 5 Accordingly, new vessels have ready access to the subretinal space and they penetrate from the choriocapillariseBruch's membraneeRPE complex anteriorly and laterally. The hypothesis is also supported by the observation of type 2 CNV in other inflammatory conditions such as serpiginous choroiditis and POHS 5 6 Non-inflammatory focal neovascular maculopathies 
